994 research outputs found
Letter by Niccoli et al regarding article, "intracoronary versus intravenous administration of abciximab in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of st-segment elevation myocardial infarction (CICERO) trial"
No full textN/
Letter by Niccoli et al regarding article, "presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention
No full textMyocardial Infarction With Nonobstructive Coronary Atherosclerosis: The Need for Precision Medicine
No full textAspetti critici delle linee guida con particolare riferimento alle sindromi coronariche acute. Cardiologia 2002
No full textMs. 2748
No full textManuscrito número 2748 de la Biblioteca Histórica de la USAL156 hojas : pergamino ; 204 x 132 mmManuscrito copiado por dos copistas en Mantua hacia 1433, para Niccolò Niccoli, a partir de un manuscrito de Vittorino da Feltre (cf. Martínez Manzano)Procede del Colegio de San Bartoloméf. 1-26: Iulianus imperator, Convivium;
f. 26-60: Iulianus imperator. Oratio II de gestis imperatoris [incompleto];
f. 61-120: Arístides Quintilianus, De musica [falto del libro tercero];
f. 121-130: Bacchius Senex, introductio methodica ad musicam;
f. 130-134: Pseudo-Bacchius Senex, introductio methodica ad musicam;
f. 134: Epigramma ad Bacchium;
f. 134-136: Mesomedes, Himnos a la musa Calíope, al Sol y a Némesi;
f. 137-153: Pseudo-Herodoto, Vida de Homer
A Multi Target and Multi Timing Strategy for the Management of Coronary Microvascular Obstruction
No full textST-segment elevation myocardial infarction (STEMI) complicated by coronary microvascular obstruction (CMVO) is one of the major causes of death and of decrease of patient’s quality of life due to recurrent myocardial infarction and heart failure. High costs for health system are associated with death and recurrent hospitalization of STEMI patients. No single treatment against CMVO is currently considered effective to improve the clinical outcome so far of STEMI patients and their quality of life. This chapter will describe how different temporal windows may be used and integrated for treating CMVO starting from the pre-hospital to the coronary care unit phase
Outcomes following coronary stenting and a role for eosinophils: evidence from eosinophil cationic protein
No full textAngiogenesis and Microvascular Obstruction: Still a Research Topic or a New Therapeutic Target?
No full text- …
